BRCA1
Showing 1 - 25 of 889
Ultra-rapid BRCA1/2 Status Screening Test in Theranostic
Not yet recruiting
- Breast Cancer
- Questionnaires
- Communication of the results of the BRCA1/2 ultra rapid test
- (no location specified)
Oct 26, 2023
Germline Variant Carriers With BRCA1 or BRCA2
Recruiting
- BRCA1 and/or BRCA2 Variant Carriers
- +3 more
-
Okayama, JapanOkayama University
Dec 25, 2022
BRCA1/2 Flu Vaccine
Active, not recruiting
- BRCA1 Mutation
- BRCA2 Mutation
- Seasonal influenza vaccine
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Aug 16, 2022
PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES
Not yet recruiting
- BRCA Mutation
- +2 more
- Germinal BRCA
- (no location specified)
Mar 3, 2023
Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)
Recruiting
- Breast Cancer
- Genetic Predisposition
- Genetic predisposition to breast cancer
-
Rome, Italy
- +1 more
May 4, 2023
Breast Cancer BRCA1 Carriers: a Pilot Study
Withdrawn
- BRCA1 Mutation
- +2 more
- Mifepristone 200 MG
- Prophylactic mastectomy
-
Carmel, Indiana
- +1 more
Dec 13, 2022
Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)
Active, not recruiting
- Breast Cancer
- +3 more
-
Boston, Massachusetts
- +2 more
Dec 21, 2022
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +5 more
- Durvalumab
- +3 more
-
Buffalo, New York
- +1 more
Jan 20, 2023
Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)
Completed
- Breast Cancer
- Pegylated liposomal doxorubicin
-
Tucson, Arizona
- +1 more
Jan 9, 2023
BRCA and NACT in TNBC Patients
Completed
- Triple-Negative Breast Cancer
- BRCA1/2 genetic testing
-
Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023
Endocrine Disruptors and Life STILe in Breast Cancer Development
Recruiting
- Breast Cancer
- +5 more
-
Roma, ItalyAlessandra Fabi
Feb 25, 2023
Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)
Not yet recruiting
- Prostate Cancer
- +4 more
- Olaparib
- LHRH agonist
- (no location specified)
Aug 10, 2022
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,
Not yet recruiting
- Pancreatic Acinar Cell Carcinoma
- +6 more
- Nab paclitaxel
- +5 more
- (no location specified)
Oct 30, 2023
BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)
Active, not recruiting
- BRCA1 Mutation
- +4 more
- Talazoparib Oral Capsule
-
Providence, Rhode Island
- +1 more
Nov 30, 2022
Hereditary Breast and Ovarian Cancer Trial in Cologne, Kiel, Munich (Structured exercise training plus mediterranean diet)
Active, not recruiting
- Hereditary Breast and Ovarian Cancer
- Structured exercise training plus mediterranean diet
-
Cologne, Germany
- +2 more
Oct 25, 2022
Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2
Recruiting
- Hereditary Breast and Ovarian Cancer
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Jun 3, 2022
Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)
Not yet recruiting
- Recurrent Metastatic Melanoma
- +3 more
-
Boston, Massachusetts
- +1 more
Jul 29, 2022
Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)
Not yet recruiting
- Triple Negative Breast Neoplasms
- +7 more
- Pembrolizumab
- +4 more
- (no location specified)
Aug 1, 2022
Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)
Active, not recruiting
- Advanced Breast Cancer
- +2 more
- Talazoparib Tosylate
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Nov 16, 2022
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Mar 28, 2023
InheriteD brEast caNcer iTalian regIsTrY A
Recruiting
- Breast Cancer
-
Aviano, Pordenone, Italy
- +11 more
Apr 26, 2023
Women With BRCA1 Germline Deleterious Mutation Trial in France (Blood sampling)
Completed
- Women With BRCA1 Germline Deleterious Mutation
- Blood sampling
-
Lyon, France
- +3 more
Jan 18, 2022
BRCA1/2 Mutation Trial in Philadelphia (INO-5401, INO-9012, Cellectra 2000)
Recruiting
- BRCA1/2 Mutation
- INO-5401
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Dec 7, 2021